Multiplex Molecular Diagnostics (MULDIA) S.L. is a company that belongs under the Brill group. We are focused on the development, registration, industrialization and commercialization of Advanced IVD Molecular Diagnosis systems.
The main objective of the system is to assist in the diagnosis, monitoring, and prognosis of different diseases, such as cancer, as well as the identification of risk factors.
MULDIA has acquired the know-how and industrial property based on granted patents awarded to the Centro de Tecnología Biomédica (CTB) from the Universidad Politécnica de Madrid (UPM).
MULDIA employs qualified multidisciplinary personnel (engineers, biologist, physicists, chemists and biomedical) working together with the CTB.
The company is active in the direct distribution of diagnostic kits and kits, the distribution through third parties through licensing agreements for specific applications, and the provision of services in areas such as public health, research, the food industry or general analytical laboratories.
Partner with Us
-We believe in partnerships.
-We are not looking for “clients” or “customers” but for partners.
-We believe in long-term relationships that bring value to both businesses.
-We believe in win-wins.
-We are not looking for “clients” or “customers” but for partners.
-We believe in long-term relationships that bring value to both businesses.
-We believe in win-wins.
Interested in partner with us?
Then why not send us an email?
Multiplex Molecular Diagnostics, S.L. is a startup company belonging to the Brill group of companies. Created in 2022 is focused on the development, registration, industrialization and commercialization of Advanced IVD Molecular Diagnostics systems.
Copyright 2022, Multiplex Molecular Diagnostic, S.L.. All rights reserved. Privacy Policy, Legal Notice, Cookies Policy.